跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,223 条关于
“MNKD-102”
全部
10,223
临床试验
4,677
药物
4,329
机构
16
资讯
1,201
10个月前
MannKind Discontinues Phase 3 Trial of Nebulized Clofazimine for NTM Lung Disease Due to Futility
2年前
UGN-102 Shows Durable Response in Non-Muscle Invasive Bladder Cancer Trial
2年前
LB Pharmaceuticals Advances Schizophrenia Treatment with LB-102
去年
Ultragenyx's GTX-102 Shows Positive Phase 1/2 Data for Angelman Syndrome, Phase 3 Enrollment to Begin by Year-End
去年
FDA Advisory Committee Rejects UroGen's Bladder Cancer Therapy UGN-102
去年
Ultragenyx's GTX-102 Shows Sustained Improvement in Angelman Syndrome Patients in Phase 1/2 Data
3个月前
MannKind Corporation Receives FDA Approval for Afrezza Inhaled Insulin in Pediatric Diabetes Patients
去年
Tonix Pharmaceuticals Submits NDA for TNX-102 SL in Fibromyalgia
去年
Ultragenyx's GTX-102 Shows Promise in Angelman Syndrome Phase 1/2 Trial
去年
EnteroBiotix's EBX-102 Shows Promise in Phase 1b Liver Cirrhosis Study
第 1 页,共 121 页
上一页
下一页